Kinsley Stephanie, Giovane Richard Anthony, Daly Sandra, Shulman David
Family Medicine, The University of Alabama System, Tuscaloosa, Alabama, USA.
Family Medicine, RMCCA, UAB System, Greenville, Alabama, USA
BMJ Case Rep. 2020 Dec 10;13(12):e238187. doi: 10.1136/bcr-2020-238187.
Marchiafava-Bignami disease (MBD) is a rare, toxic demyelinating disorder of the central nervous system associated with chronic alcoholism and malnutrition. The clinical presentation is varied and non-specific, including symptoms of acute dementia, impaired consciousness, dysarthria, hemiparesis, pyramidal tract signs, seizure activity, ataxia and signs of interhemispheric disconnection. The differential diagnosis of MBD may include Wernicke's encephalopathy, multiple sclerosis, encephalitis, infectious or paraneoplastic leucoencephalopathy, infarction, Alzheimer's disease, multi-infarct dementia and frontotemporal lobar degeneration (Pick) disease. The diagnosis of MBD is dependent on MRI findings of hyperintensity of the corpus callosum on T2 and fluid-attenuated inversion recovery T2 sequences, with or without extracallosal lesions. The use of MRI in diagnosis has allowed for early initiation of treatment with parenteral thiamine, and improved the prognosis of MBD from frequently fatal to a mortality of less than 8%. Administration of thiamine within 14 days of symptom onset has demonstrated statistically better outcomes over delayed treatment. We present a case report of MBD diagnosed in a 72-year-old woman who presented with ataxia and slurred speech, in an effort to highlight the importance of obtaining MRI in patients presenting with behavioural disturbance and neurological findings, as well as discuss the relationship between thiamine supplementation and demyelinating diseases in the central nervous system.
马基亚法瓦-比尼亚米病(MBD)是一种罕见的、与慢性酒精中毒和营养不良相关的中枢神经系统中毒性脱髓鞘疾病。临床表现多样且不具特异性,包括急性痴呆、意识障碍、构音障碍、偏瘫、锥体束征、癫痫发作、共济失调以及大脑半球间联系中断的体征。MBD的鉴别诊断可能包括韦尼克脑病、多发性硬化、脑炎、感染性或副肿瘤性白质脑病、梗死、阿尔茨海默病、多发梗死性痴呆和额颞叶痴呆(匹克)病。MBD的诊断依赖于磁共振成像(MRI)在T2加权像和液体衰减反转恢复序列T2加权像上胼胝体高信号的表现,可伴有或不伴有胼胝体外病变。MRI在诊断中的应用使得能够早期开始胃肠外给予硫胺素治疗,并将MBD的预后从通常致命改善为死亡率低于8%。在症状出现后14天内给予硫胺素治疗在统计学上比延迟治疗有更好的结果。我们报告一例72岁女性被诊断为MBD的病例,该患者表现为共济失调和言语含糊,旨在强调对于出现行为障碍和神经系统表现的患者进行MRI检查的重要性,并讨论硫胺素补充与中枢神经系统脱髓鞘疾病之间的关系。